Logo image of ASL.CA

ARGENTUM SILVER CORP (ASL.CA) Stock Fundamental Analysis

Canada - TSX-V:ASL - CA04014D2068 - Common Stock

0.14 CAD
-0.06 (-30%)
Last: 11/13/2025, 7:00:00 PM
Fundamental Rating

0

ASL gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 799 industry peers in the Metals & Mining industry. ASL has a bad profitability rating. Also its financial health evaluation is rather negative. ASL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ASL had negative earnings in the past year.
In the past year ASL has reported a negative cash flow from operations.
ASL had negative earnings in each of the past 5 years.
ASL had a negative operating cash flow in each of the past 5 years.
ASL.CA Yearly Net Income VS EBIT VS OCF VS FCFASL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500K -1M -1.5M

1.2 Ratios

ASL's Return On Assets of -411.67% is on the low side compared to the rest of the industry. ASL is outperformed by 86.61% of its industry peers.
Industry RankSector Rank
ROA -411.67%
ROE N/A
ROIC N/A
ROA(3y)-91.04%
ROA(5y)-91.39%
ROE(3y)-315.37%
ROE(5y)-234.67%
ROIC(3y)N/A
ROIC(5y)N/A
ASL.CA Yearly ROA, ROE, ROICASL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ASL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASL.CA Yearly Profit, Operating, Gross MarginsASL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, ASL has about the same amount of shares outstanding.
ASL has more shares outstanding than it did 5 years ago.
ASL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ASL.CA Yearly Shares OutstandingASL.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASL.CA Yearly Total Debt VS Total AssetsASL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M

2.2 Solvency

Based on the Altman-Z score of -208.15, we must say that ASL is in the distress zone and has some risk of bankruptcy.
ASL has a worse Altman-Z score (-208.15) than 87.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -208.15
ROIC/WACCN/A
WACCN/A
ASL.CA Yearly LT Debt VS Equity VS FCFASL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K

2.3 Liquidity

ASL has a Current Ratio of 0.54. This is a bad value and indicates that ASL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.54, ASL is doing worse than 70.46% of the companies in the same industry.
A Quick Ratio of 0.54 indicates that ASL may have some problems paying its short term obligations.
The Quick ratio of ASL (0.54) is worse than 68.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
ASL.CA Yearly Current Assets VS Current LiabilitesASL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

ASL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.25%.
EPS 1Y (TTM)-6.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASL.CA Price Earnings VS Forward Price EarningsASL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASL.CA Per share dataASL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARGENTUM SILVER CORP

TSX-V:ASL (11/13/2025, 7:00:00 PM)

0.14

-0.06 (-30%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-17 2025-10-17
Earnings (Next)11-21 2025-11-21
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.22M
Revenue(TTM)N/A
Net Income(TTM)-349.10K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -411.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-91.04%
ROA(5y)-91.39%
ROE(3y)-315.37%
ROE(5y)-234.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z -208.15
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.45%
OCF growth 3YN/A
OCF growth 5YN/A

ARGENTUM SILVER CORP / ASL.CA FAQ

What is the ChartMill fundamental rating of ARGENTUM SILVER CORP (ASL.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to ASL.CA.


Can you provide the valuation status for ARGENTUM SILVER CORP?

ChartMill assigns a valuation rating of 0 / 10 to ARGENTUM SILVER CORP (ASL.CA). This can be considered as Overvalued.


How profitable is ARGENTUM SILVER CORP (ASL.CA) stock?

ARGENTUM SILVER CORP (ASL.CA) has a profitability rating of 0 / 10.